<DOC>
	<DOC>NCT00384904</DOC>
	<brief_summary>The purpose of this clinical research study is to assess the effect of Famotidine given twice daily on Atazanavir administered with Ritonavir in HIV-Infected subjects.</brief_summary>
	<brief_title>Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Famotidine</mesh_term>
	<criteria>HIVinfected male and female subjects between the ages of 18 to 65 years old with a BMI 18 to 35 kg/m² Prior to enrollment subjects must be currently receiving Atazanavir/Ritonavir plus at least 2 NRTIs, must have plasma HIV RNA &lt;400 copies/mL and have CD4 count &gt;200 cells/mm³</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2008</verification_date>
</DOC>